Fundraising Fox

Hugh Rosen

Investor

Chair, Department of Molecular and Cellular Biology, Scripps (Scientific Advisory Board member) at Red Tree Venture

La Jolla, California

About

Hugh Rosen is Pearson Family Professor and Chair of the Department of Molecular and Cellular Biology at Scripps Research Institute, where his work focuses on the chemical biology of immune regulation by signaling lipids and receptor therapeutics. Working with Edward Roberts, his lab invented ozanimod (marketed by Bristol-Myers Squibb as Zeposia for MS and ulcerative colitis) and additional clinical-stage compounds. He earned his MB.ChB. from the University of Cape Town and a D.Phil. in Physiological Sciences from Oxford, and previously held leadership roles at Merck Research Laboratories.

Invests in

AI & Machine LearningBiotech

Colleagues at Red Tree Venture

Adam Silverman
Red Tree Venture Labs Biologics at Red Tree Venture
Antonio Lepore
Senior Associate at Red Tree Venture
Ariell Ortega
Executive Assistant at Red Tree Venture
Bill Robinson
Scientific Advisory Board - Immunology; Chief, Stanford Division of Immunology and Rheumatology at Red Tree Venture
Brian Stearns
Red Tree Venture Labs Chemistry at Red Tree Venture
Cassie Lue
VP of Investor Relations at Red Tree Venture
Crystal Mackall
Scientific Advisory Board - Oncology; Director, Stanford Center for Cancer Cell Therapy at Red Tree Venture
Deborah Nguyen
Red Tree Venture Labs Operating Partner at Red Tree Venture